1. Horgan NF, O'Regan M, Cunningham CJ, Finn AM. Recovery after stroke: a 1-year profile. Disabil Rehabil. 2009; 31(10):831–839.

2. Wade DT, Wood VA, Hewer RL. Recovery after stroke--the first 3 months. J Neurol Neurosurg Psychiatry. 1985; 48(1):7–13.

3. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC, et al. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005; 62(3):393–397.

4. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004; 62(4):569–573.

5. Lee JS, et al. Prognostic modeling for an efficacy and a safety of thrombolysis in acute ischemic stroke. J Korean Neurol Assoc. 2012; 30:100–109.
6. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010; 41(9):1990–1995.
7. von Kummer R, Mori E, Truelsen T, Jensen JS, Grønning BA, Fiebach JB, et al. Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 trial (efficacy and safety study of desmoteplase to treat acute ischemic stroke). Stroke. 2016; 47(12):2880–2887.
8. Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016; 47(9):2373–2379.
9. Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke. 2004; 35(1):147–150.

10. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology. 2005; 65(8):1169–1174.

11. Muresan IP, Favrole P, Levy P, Andreux F, Marro B, Alamowitch S. Very early neurologic improvement after intravenous thrombolysis. Arch Neurol. 2010; 67(11):1323–1328.

12. Takagi T, Kato T, Sakai H, Nishimura Y. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy. J Stroke Cerebrovasc Dis. 2014; 23(1):69–74.

13. Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008; 26(4):381–387.
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24):1581–1587.
15. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001; 32(11):2559–2566.

16. Berges IM, Kuo YF, Ottenbacher KJ, Seale GS, Ostir GV. Recovery of functional status after stroke in a tri-ethnic population. PM R. 2012; 4(4):290–295.

17. Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, et al. Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Int J Stroke. 2014; 9(4):514–518.

18. Kim BJ, Park JM, Kang K, Lee SJ, Ko Y, Kim JG, et al. Case characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South Korea. J Stroke. 2015; 17(1):38–53.

19. Veerbeek JM, Kwakkel G, van Wegen EE, Ket JC, Heymans MW. Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke. 2011; 42(5):1482–1488.
20. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35–41.

21. Ko Y, Lee S, Chung JW, Han MK, Park JM, Kang K, et al. MRI-based algorithm for acute ischemic stroke subtype classification. J Stroke. 2014; 16(3):161–172.

22. Lai SM, Duncan PW. Stroke recovery profile and the Modified Rankin assessment. Neuroepidemiology. 2001; 20(1):26–30.

23. Mikulik R, Ribo M, Hill MD, Grotta JC, Malkoff M, Molina C, et al. Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke. Circulation. 2007; 115(20):2660–2665.

24. Gauvreau K, Pagano M. The analysis of correlated binary outcomes using multivariate logistic regression. Biom J. 1997; 39(3):309–325.

25. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453–1457.

26. Ullberg T, Zia E, Petersson J, Norrving B. Changes in functional outcome over the first year after stroke: an observational study from the Swedish stroke register. Stroke. 2015; 46(2):389–394.
27. Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N, et al. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke. 2011; 42(6):1638–1643.

28. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008; 7(10):915–926.

29. Paolucci S, Bragoni M, Coiro P, De Angelis D, Fusco FR, Morelli D, et al. Is sex a prognostic factor in stroke rehabilitation? A matched comparison. Stroke. 2006; 37(12):2989–2994.
30. Kim JS, Lee KB, Roh H, Ahn MY, Hwang HW. Gender differences in the functional recovery after acute stroke. J Clin Neurol. 2010; 6(4):183–188.

31. Vaughan CJ. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol. 2003; 91:4A. 23B–29B.
32. Bagg S, Pombo AP, Hopman W. Effect of age on functional outcomes after stroke rehabilitation. Stroke. 2002; 33(1):179–185.

33. Choi JC, Jang MU, Kang K, Park JM, Ko Y, Lee SJ, et al. Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke. J Am Heart Assoc. 2015; 4(1):e001306.

34. Dallas MI, Rone-Adams S, Echternach JL, Brass LM, Bravata DM. Dependence in prestroke mobility predicts adverse outcomes among patients with acute ischemic stroke. Stroke. 2008; 39(8):2298–2303.

35. Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol. 2010; 10(1):47.

36. Formisano R, Pantano P, Buzzi MG, Vinicola V, Penta F, Barbanti P, et al. Late motor recovery is influenced by muscle tone changes after stroke. Arch Phys Med Rehabil. 2005; 86(2):308–311.

37. Sharma N, Cohen LG. Recovery of motor function after stroke. Dev Psychobiol. 2012; 54(3):254–262.

38. Duncan PW, Goldstein LB, Horner RD, Landsman PB, Samsa GP, Matchar DB. Similar motor recovery of upper and lower extremities after stroke. Stroke. 1994; 25(6):1181–1188.

39. Park TH, Ko Y, Lee SJ, Lee KB, Lee J, Han MK, et al. Gender differences in the age-stratified prevalence of risk factors in Korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study. Int J Stroke. 2014; 9(6):759–765.

40. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011; 377(9778):1693–1702.

41. Lynch E, Hillier S, Cadilhac D. When should physical rehabilitation commence after stroke: a systematic review. Int J Stroke. 2014; 9(4):468–478.
